Anthony Grenier

Anthony Grenier is a seasoned professional in the pharmaceutical industry with extensive experience in technology transfer, product development, and process development. Currently serving as Sr Director CMC at Reunion Neuroscience since January 2023, Anthony plays a crucial role in developing product strategies from discovery to commercial scale. Previously, as an Independent Pharmaceutical Consultant at Tech Transfer & Outsourcing Solutions, Anthony supported small and virtual pharma companies in acquiring products and sourcing contract manufacturing organizations globally. Notable past positions include Sr Director at Acasti Pharma, where Anthony focused on krill oil-based omega-3 therapies, and Manager of Technology Transfer & Sourcing at Paladin Labs, where over 20 products were transferred from Big Pharma. With early career roles at Wyeth, Skyepharma, Ethypharm, and Technilab, Anthony has built a strong foundation in pharmaceutical development, complemented by a Chemical Engineering degree from Ecole nationale supérieure de Chimie et de Physique de Bordeaux.